PathologyWatch Overview
- Year Founded
-
2017

- Status
-
Acquired/Merged
- Employees
-
62

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$150M
PathologyWatch General Information
Description
Developer of a digital pathology platform designed to detect and characterize cancers from biopsy samples. The company's platform takes histologic slides from any location and digitally distributes the work across a network of skilled experts who provide instant remote access to a workforce of academic-level dermatopathologists, digital tools, and expert consultation, enabling healthcare professionals to significantly become efficient in diagnosing skin cancer.
Contact Information
Website
www.pathologywatch.com(Operating Subsidiary)
Corporate Office
- 370 South 300 East
- Salt Lake City, UT 84111
- United States
Corporate Office
- 370 South 300 East
- Salt Lake City, UT 84111
- United States
PathologyWatch Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Merger/Acquisition | 08-Jan-2024 | $150M | Completed | Generating Revenue | ||
8. General Corporate Purpose | 17-Apr-2023 | Completed | Generating Revenue | |||
7. Secondary Transaction - Private | 30-Mar-2023 | Completed | Generating Revenue | |||
6. Later Stage VC | 06-Mar-2023 | Completed | Generating Revenue | |||
5. Early Stage VC (Series B) | 16-Nov-2021 | Completed | Generating Revenue | |||
4. Accelerator/Incubator | 30-May-2021 | Completed | Generating Revenue | |||
3. Early Stage VC (Series A) | 16-Dec-2020 | Completed | Generating Revenue | |||
2. Seed Round | 07-May-2019 | $2.34M | $2.34M | Completed | Generating Revenue | |
1. Accelerator/Incubator | Completed | Generating Revenue |
PathologyWatch Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series A | ||||||||
Seed-2 | 87,379 | $0.000100 | $7 | $7 | 1x | $7 | 3.29% | |
Seed-1 | 270,383 | $0.000100 | $10.36 | $10.36 | 1x | $10.36 | 10.19% |
PathologyWatch Comparisons
Industry
Financing
Details
PathologyWatch Competitors (1)
One of PathologyWatch’s competitors is Indica Labs, a Venture Capital-Backed company based in Albuquerque, NM.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Indica Labs | Venture Capital-Backed | Albuquerque, NM |
PathologyWatch Patents
PathologyWatch Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20250061983-A1 | Systems, methods, and devices for a cancer pathology laboratory information system (lis) | Pending | 19-Aug-2023 | ||
US-20250061984-A1 | Dynamic cancer pathology laboratory information systems, methods, and devices | Pending | 19-Aug-2023 | ||
US-20240321449-A1 | Systems, methods, and devices for melanoma pathology using one or more neural networks | Pending | 24-Mar-2023 | G16H50/20 |
PathologyWatch Signals
PathologyWatch Former Investors (24)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
37 Angels | Angel Group | Minority | ||
AWS Startups | Accelerator/Incubator | |||
Angel (individual) | Minority | |||
Beni Venture Capital | Impact Investing | Minority | ||
BioVentures Investors | Venture Capital | Minority |
PathologyWatch FAQs
-
When was PathologyWatch founded?
PathologyWatch was founded in 2017.
-
Where is PathologyWatch headquartered?
PathologyWatch is headquartered in Salt Lake City, UT.
-
What is the size of PathologyWatch?
PathologyWatch has 62 total employees.
-
What industry is PathologyWatch in?
PathologyWatch’s primary industry is Laboratory Services (Healthcare).
-
Is PathologyWatch a private or public company?
PathologyWatch is a Private company.
-
What is the current valuation of PathologyWatch?
The current valuation of PathologyWatch is
. -
What is PathologyWatch’s current revenue?
The current revenue for PathologyWatch is
. -
How much funding has PathologyWatch raised over time?
PathologyWatch has raised $57.2M.
-
Who are PathologyWatch’s investors?
37 Angels, AWS Startups, , Beni Venture Capital, and BioVentures Investors are 5 of 24 investors who have invested in PathologyWatch.
-
Who are PathologyWatch’s competitors?
Indica Labs is a competitor of PathologyWatch.
-
When was PathologyWatch acquired?
PathologyWatch was acquired on 08-Jan-2024.
-
Who acquired PathologyWatch?
PathologyWatch was acquired by Sonic Healthcare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »